You are here: Industry Insights > hypoglycaemia

News List

US FDA approves first generic glucagon injection to treat severe hypoglycaemia expresspharma
December 29, 2020
The FDA granted this approval to Amphastar Pharmaceuticals of Rancho Cucamonga, California.
Zealand announces confirmatory Phase III results in hypoglycaemia pharmaceutical-technology
May 15, 2019
Copenhagen-based Zealand Pharma has announced positive results from a Phase III confirmatory study investigating dasiglucagon in patients with severe hypoglycaemia related to diabetes.
Ready-to-use glucagon for exercise-induced hypoglycaemia europeanpharmaceuticalreview
March 21, 2019
This study will evaluate the ready-to-use, room-temperature stable liquid glucagon as a pre-treatment to prevent exercise-induced hypoglycemia…
Novo Nordisk participates in new research project Hypo-RESOLVE to investigate hypoglycaemia and its impact in diabetes worldpharmanews
May 03, 2018
Within the newly started European research project Hypo-RESOLVE, 23 leading international players from academia...
Switching to Tresiba® Provides Significant Reductions in Blood Glucose and Lower Rates of Hypoglycae en-cphi.cn
June 12, 2017
Findings from the real-world study, EU-TREAT (EUropean TREsiba AudiT), were presented today at the American Diabetes Association's 77th Scientific Sessions (ADA) in San Diego, US.